Thursday, October 22, 2026

Marc ZERBOLA CHALLANDE

497 POSTS
Marc has been involved in the Stock Market Media Industry for the last +5 years. After obtaining a college degree in engineering in France, he moved to Canada, where he created Money,eh?, a personal finance website.

Exclusive articles:

Mangoceuticals (MGRX): Can MGRX Stimulate the Stock Market’s Morning Glory?

In the throes of a global economic downturn, investors are on the lookout for any sign of vitality in the stock market. Enter Mangoceuticals...

Gold Prices Surge Amid Global Uncertainty

Gold prices are experiencing a historic rally in 2025, breaking new records and attracting strong investor interest amid rising geopolitical tensions and fears of...

Trump’s Tariffs Spark Stock Market Turmoil: A Mid-2025 Meltdown

Wall Street just had its worst week since 2020 — and you can thank tariffs for that. President Donald Trump's "Liberation Day" tariffs, unveiled in...

Trump Imposes 25% Tariffs on Imported Autos, Prompting Global Backlash

President Donald Trump has announced a 25% tariff on imported automobiles and parts, effective April 3, 2025—a move expected to generate $100 billion annually...

Mangoceuticals, Inc. (NASDAQ: MGRX) Secures Exclusive Rights to Diabetinol®, Entering $33.6 Billion Diabetes Market

Mangoceuticals, Inc. (NASDAQ: MGRX), operating as MangoRx, is a Dallas-based telemedicine company specializing in men's health and wellness. The company offers treatments for conditions...

Breaking

AI’s $466 Billion Borrowing Boom Meets Earnings Season

The AI trade is facing a financing test. Companies...

Sekur’s Multilingual Growth Bet and the Earnings Upside

Sekur’s two language launches could open a larger opportunity...

 Sekur’s Multilingual Growth Bet: Why a Few Hundred Customers Could Matter 

 Sekur’s international expansion is entering a more concrete phase. Portuguese...

SpaceX and the chip stock selloff

SpaceX poured $15.8 billion into its AI division in...
spot_img